Imaflex receives USPTO’s approval for Advaseal
by CM Staff
Imaflex requires U.S. EPA approval before bringing Advaseal to the market.
MONTRÉAL — The United States Patent and Trademark Office (USPTO) has granted Imaflex U.S. patent number 11,992,0091 for its “pesticide-containing soil disinfestation material without use of fumigant” (Advaseal). This patent is valid until 2041.
Advaseal reportedly eliminates the need for harmful fumigants and disinfects the soil while minimizing the environmental impact, offering a more sustainable approach to agricultural practices.
“This recognition underscores our commitment to developing innovative solutions that address the needs of the agricultural industry while promoting environmental responsibility. We are confident that Advaseal could play a significant role in promoting sustainable agricultural practices, and we are actively working to bring this product to market as soon as possible,” said Joe Abbandonato, president and CEO of Imaflex.
However, the company requires U.S. Environmental Protection Agency (EPA) approval before Advaseal can be brought to market.
